Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

GlobeNewswire EN Nachrichten

GlobeNewswire verbreitet Pressemeldungen und Pflichtmitteilungen von börsennotierten Gesellschaften. Der Großteil der Mitteilungen stammt von Unternehmen aus Nordamerika, Großbritannien und den nordeuropäischen Ländern.
 
27.12.25 - 19:45
Senvest Capital Inc. Announces Death of Chief Executive Officer and Chairman of the Board (GlobeNewswire EN)
 
MONTREAL, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Senvest Capital Inc. (the “Corporation” or “Senvest”) (TSX: SEC) announces with profound sadness the passing of its founder and long-time leader, Victor Mashaal, who served as President, Chief Executive Officer, and Chairman of the Board of Directors. Victor passed away at the age of 87 following a brief illness. He was a deeply respected and admired leader and a mentor to the entire Senvest family. He will be greatly missed....
27.12.25 - 00:00
MEDIROM Partners with World (GlobeNewswire EN)
 
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex Blania Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex Blania...
26.12.25 - 23:45
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) (GlobeNewswire EN)
 
NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Southpoint Capital Advisors LP (“Southpoint”), acting on behalf of certain Southpoint funds for which it serves as investment manager, announces that on December 24, 2025, pursuant to securities laws, it disposed of beneficial ownership of 1,000,000 common shares (a “Common Share”) of Fennec Pharmaceuticals Inc. (“Fennec”), representing approximately 2.93% of the outstanding Common Shares (calculated on a fully diluted basis)....
26.12.25 - 23:03
Outlook Therapeutics Announces New Employment Inducement Grants (GlobeNewswire EN)
 
ISELIN, N.J., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that effective December 19, 2025, the Outlook Therapeutics, Inc. Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 150,000 shares of Outlook Therapeutics common stock with a per share exercise price of $2.01 per share to two new employees....
26.12.25 - 22:39
Brookfield Real Assets Income Fund Inc. Declares Q1 2026 Distribution Schedule (GlobeNewswire EN)
 
NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Brookfield Real Assets Income Fund Inc. (NYSE: RA) (the “Fund”) today announced that its Board of Directors (the “Board”) declared the Fund's monthly distributions for January, February and March 2026....
26.12.25 - 22:18
Cycurion, Inc. (NASDAQ: CYCU) Announces Corrected Dividend Distribution Ratio of 0.0080 in Connection with its Previously Announced $500,000 Common Share Dividend (GlobeNewswire EN)
 
MCLEAN, Va., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”) refers to the press release dated December 11, 2026, in which the Company announced a dividend distribution ratio of 0.0180 in connection with the previously announced pro-rata distribution of approximately $500,000 of CYCU shares to its own shareholders (on a fully diluted basis). Cycurion today announces a corrected dividend distribution ratio of 0.0080, which takes into consideration the common shares issuable upon the exercise of the Company's warrants that were issued in connection with the previously announced private placement that closed on December 5, 2025. Except for the correction described above, all other terms and conditions of the dividend remain unchanged....
26.12.25 - 20:00
Fitell Corporation Announces Interim Dividend and Shareholder Loyalty Program (GlobeNewswire EN)
 
Taren Point, Australia, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Fitell Corporation (NASDAQ: FTEL) (“Fitell” or the “Company”) announced its board of directors (the “Boards”) of the Company has declared two initiatives – an interim dividend and a one-time shareholder loyalty program – both designed to return value to shareholders and enhance long-term investor alignment with the Company's evolving growth strategy....
26.12.25 - 17:00
Atos Group has signed a binding agreement to sell its Atos operations in South America to the Brazilian company Semantix (GlobeNewswire EN)
 
Atos Group announces that it has signed a binding agreement for the sale of its South American operations to the Brazilian company Semantix....
26.12.25 - 15:33
ECD Auto Design Announces Expanded 2026 Product Lineup, Including New Heritage Programs, Modern Platforms, and Upgraded Safety Innovations (GlobeNewswire EN)
 
ECD announcing a major expansion of its product lineup for 2026. The new programs span heritage-inspired sports coupes, classic SUVs, and modern lifestyle....
26.12.25 - 15:21
Golden Triangle Ventures Establishes Snapt Beverages as Its Manufacturing and Brand Development Division (GlobeNewswire EN)
 
AUSTIN, Texas, Dec. 26, 2025 (GLOBE NEWSWIRE) -- via IBN -- Golden Triangle Ventures (OTC: GTVH) today announced the establishment of Snapt Beverages as its manufacturing and brand development division. Snapt Beverages operates as a wholly owned subsidiary, strengthening Golden Triangle Ventures' foundation as a vertically integrated consumer products platform built for scale....
26.12.25 - 15:03
DAILY JOURNAL CORPORATION ADDRESSES BUXTON HELMSLEY′S BRAZEN THREATS AND EXPOSES THE FIRM′S DISINGENUOUS, SELF-SERVING AGENDA (GlobeNewswire EN)
 
The Company has Referred Buxton and its CEO, Alexander Erwin Parker, to Federal and State Authorities for Consideration of Criminal Prosecution...
26.12.25 - 14:48
Nexxen Announces Updates to 2025 Annual General Meeting Proposals (GlobeNewswire EN)
 
NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that it has published a Supplemental Proxy Statement in connection with its 2025 Annual General Meeting of Shareholders scheduled for December 30, 2025 (the “AGM”)....
26.12.25 - 14:33
City of Cedar Rapids, IA Selects 374Water to Perform Project for PFAS Destruction in Biosolids (GlobeNewswire EN)
 
City of Cedar Rapids, IA selects 374Water to Perform Project for PFAS Destruction in Biosolids...
26.12.25 - 14:33
Champion Safe Company Recognizes West Side Safe and Gun of Marietta, Ohio for Strong Growth and Community Impact (GlobeNewswire EN)
 
Champion Safe Orders from Marietta's West Side Safe & Gun Surge 104% Year-Over-Year...
26.12.25 - 14:33
TechForce Robotics to Exhibit at CES 2026, Showcasing Full Portfolio of Proprietary Robotics Technologies and Accepting Customer Orders (GlobeNewswire EN)
 
LOS ANGELES, Dec. 26, 2025 (GLOBE NEWSWIRE) -- via IBN -- Nightfood Holdings, Inc. dba TechForce Robotics (OTCQB: NGTF) (“TechForce” or the “Company”), an AI-driven service-robotics platform focused on hospitality, foodservice, and commercial automation, announces its participation at CES® 2026, taking place January 6–9, in Las Vegas, Nevada. Attendees are invited to visit TechForce Robotics at CES 2026 at Booth 6911 to experience live demonstrations and speak with the Company's team about product capabilities, deployment options, and ordering opportunities....
26.12.25 - 14:33
Celularity CEO Comments on Centers for Medicare & Medicaid Services′ Withdrawal of Skin Substitute Local Coverage Determinations (GlobeNewswire EN)
 
While Celularity's Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn LCDs, Celularity CEO Dr. Robert J. Hariri welcomed the recent action taken under the leadership of CMS Administrator Dr. Mehmet Oz While Celularity's Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn LCDs, Celularity CEO Dr. Robert J. Hariri welcomed the recent action taken under the leadership of CMS Administrator Dr. Mehmet Oz...
26.12.25 - 14:03
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire EN)
 
NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share....
26.12.25 - 14:03
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources (GlobeNewswire EN)
 
DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that on December 24, 2025, it received a notice from Roosevelt Resources, LP, terminating the Securities Exchange Agreement between Arcadia and Roosevelt dated December 4, 2024, pursuant to the terms of the agreement. The agreement provided for a proposed business combination transaction between the two companies....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Omnia conando docilis sollertia vincit - Indem sie alles versucht, kommt gelehrige Sorgfalt ans Ziel. - Marcus Manilius
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!